Benzinga··Vandana SinghPfizer's ELREXFIO Demonstrates Superior Efficacy in Late-Stage Myeloma Trial
Pfizer's ELREXFIO cancer therapy shows superior efficacy in Phase 3 myeloma trial, but stock declines amid analyst skepticism about growth prospects.
PFEPhase 3 trialclinical trial results